A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism

✍ Scribed by Joseph R. Moskal; Jeffrey Burgdorf; Roger A. Kroes; Stefan M. Brudzynski; Jaak Panksepp

• Book ID: 113813544
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 225 KB
• Volume: 35
• Category: Article
• ISSN: 0149-7634
• DOI: 10.1016/j.neubiorev.2011.06.006